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Summary. Cholecystokinin (CCK) is a multifunctional 
regulatory peptide, which acts through two main 
subtypes of receptors, named CCK-A and CCK-B. 
Evidence indicates that CCK modulates cell proliferation 
in various tissues in a paracrine manner, and proofs are 
available of the presence of CCK in both adrenal glands 
and thymus. Hence, we have investigated the possible 
mitogenic action of this peptide on these two tissues, by 
evaluating the %o of metaphase-arrested cells after 
vincristin injection (mitotic index). The  systemic 
administration of CCK (three subcutaneous injections of 
20 nmollkg, 28, 1 6  and 4 h before the sacrifice) 
increased the mitotic index in both the outer adrenal and 
thymus cortexes of immature (20-day-old) rats and the 
enucleated adrenal gland of adult (2-month-old) animals 
at day 5 and 8 of regeneration. The simultaneous 
administration of equimolar doses of a selective CCK-A 
receptor antagonist blocked the effect of CCK, while a 
CCK-B antagonist was ineffective. These findings 
indicate that CCK exerts a marked CCK-A-mediated 
proliferogenic effect on both adrenal cortex and thymus 
in the rat,  the physiological relevance of which, 
however, remains to be demonstrated. In fact, the 
administration of the CCK-A antagonist alone was 
ineffective, thereby casting doubts on the role played by 
endogenous CCK in the maintenance and stimulation of 
adrenal and thymus growth. 
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Introduction 
gut, and subsequently localized in the central nervous 
system and several peripheral organs and tissues. CCK 
acts through two main subtypes of receptors, named 
CCK-A and CCK-B, which belong to the G protein- 
coupled receptor superfamily, and which are 
predominantly located in the periphery and central 
nervous system, respectively (for review, see Crawley 
and Corwin, 1994). CCK, in addition to controlling 
digestion and exerting many behavioral actions, also 
appears to regulate in a paracrinelautocrine manner cell 
proliferation in several normal and tumorous tissues 
(Crawley and Corwin, 1994; Forguet-Lafitte et al., 1996; 
Nagata et al., 1996; Xu et al., 1996; Todisco et al., 
1997). 
Evidence indicates that CCK and its receptors are 
contained in the adrenal glands. CCK-immunoreactivity 
is present in some substance 1'-positive nerve fibers of 
the human and guinea-pig adrenals (Heym et al., 
1995a,b; Heym, 1997), as  well as  in epinephrine- 
containing cell of the chicken interrenals (Ohmori et al., 
1997). Proof is available that cat adrenal medulla 
(Gaumann and Yaksh, 1988a,b) and human pheo- 
chromocytomas (Bardram et al., 1989) are able to 
synthesize CCK, and cultured bovine adrenomedullary 
cells are provided with CCK-A receptors (Aarnisalo et 
al., 1996). Likewise, CCK and its receptors are present 
in the lymphoid tissue, including thymus (Felten et al., 
1985; Weinberg et al., 1997). 
Therefore, i t  seemed worthwhile to investigate 
whether CCK is able to modulate adrenocortical-cell and 
thymocyte proliferation in the rat. Since the mitotic rate 
in adrenals and thymus of adult animals is very low or 
negligible, we used immature rats or animals bearing 
enucleated-regenerating adrenals. 
Cholecystokinin (CCK) is a 33-amino acid Materialsand methods 
regulatory peptide originally discovered in the porcine 
Animals and reagents 
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dark cycle (illumination onset at 8:00 a.m.) at 2321 "C, 
and maintained on a standard diet and tap water ad 
libiturn. CCK (octapeptide sulfated) was purchased from 
Bachem (Bubendorf, Switzerland), and the selective 
CCK-A and CCK-B receptor antagonists PD 140,548 
and PD 135,158, respectively (Hughes et al., 1990; 
Higginbottom et al., 1993) were from Research 
Biochemicals International (Natick, MA, USA). 
Vincristin was obtained from Gedeon-Richter (Budapest, 
Hungary). 
Experimental procedures 
Under ether anaesthesia, the left adrenal gland of 
adult rats was enucleated, and the controlateral gland 
removed. Operated rats were given 0.9% NaCl to drink, 
and were killed 5 or 8 days after surgery. Groups of adult 
rats with adrenal regeneration and immature animals 
(n = 6) were given three subcutaneous injections (28, 16 
and 4 h before the sacrifice) of the following chemicals 
dissolved in 0.2 m1 0.9% NaCl: (i) CCK (20 nmolkg); 
(ii) CCK-A or CCK-B receptor antagonist (20 nmollkg); 
and (iii)  CCK plus CCK-A or  CCK-B receptor 
antagonist. Control rats were injected with saline 
vehicle. All groups of animals received an intra- 
peritonea1 injection of vincristin (0.1 mg/100 g) 180 min 
before the autopsy. Rats were decapitated at 11:OO a.m. 
Cell-proliferation assay 
Thymuses were promptly removed from immature 
rats, and capsule-adjacent fragments were fixed in 2.5% 
glutaraldehyde, postfixed in 1% osmium tetroxide, and 
embedded in Araldite; 0.5 pm-thick sections were cut, 
and stained with toluidine blue. Adrenal glands from 
immature rats and regenerating adrenals were fixed in 
melaphase index (l) 
Bouin's solution for 24 h, embedded in paraffin and 
sectioned at 5 -6  pm;  sect ions were stained with 
hematoxylin and eosin. The  mitotic index (%o of 
metaphase-arrested cells) was calculated at x400, by 
counting 5,000 cells in the subcapsular zone of each 
thymus (4-5 layers of cells) or adrenal cortex (7-9 layers 
of cells), and in the regenerating adrenal parenchyma. 
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Statistical analysis 
Individual results were averaged per experimental 
group, and SEM was calculated. The statistical 
comparison of the data was done by ANOVA, followed 
by the Multiple Range Test of Duncan. 
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Results 
+ 
CCK increased metaphase index by about 77% and 
80% in the thymus cortex and adrenal subcapsular layers 
of immature rats (Fig. 1). As expected, the mitotic 
activity was higher at day 5 of adrenal regeneration than 
at day 8, and CCK significantly enhanced it at both 
experimental t imes (by about 66% and 196%, 
respectively) (Fig. 2). The simultaneous administration 
of the CCK-A antagonist annulled the effects of CCK, 
while the CCK-B antagonist was ineffective. The 
administration of either CCK-A or CCK-B antagonists 
alone did not significantly alter basal mitotic index of all 
tissues examined (Figs. 1,2). 
+ 
Discussion 
Our present results provide clear-cut evidence that 
CCK administration markedly enhances the mitotic 
metaphase index (l) 
Flg. 1. Effects of CCK and CCK-receptor antagonists on thymocyte (left 
panel) and adrenocortical-cell (right panel) proliferation in immature rats 
(meanskSEM; n = 6). *: p<0.01 from the respective basal (B) value; 
A: p-zO.01 from the respective control group. 
Fig. 2. Effects of CCK and CCK-receptor antagonists on adrenocorlical- 
cell proliferation at day 5 (left panel) and day 8 (right panel) of rat 
adrenal regeneration after enucleation (meanskSEM; n = 6). *: p<0.01 
from the respective basal (B) value; A: p<0.01 from the respective 
control group. 
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index in both adrenal and thymus, thereby confirming 
the involvement of this peptide in the control of cell 
proliferation (see Introduction). They also indicate that 
this effect of CCK is mediated by the peripheral type 
CCK-A receptors, because it is annulled by the CCK-A 
receptor antagonist, and unaffected by the CCK-B 
receptor antagonist. The possibility of a non-specific 
toxic effect of the CCK-A receptor antagonist is ruled 
out by the demonstration that this chemical per se does 
not alter basal mitotic rate. However, our study cast 
doubts that CCK, although contained in both adrenal and 
thymus (see Introduction), acts on them in a paracrinet 
autocrine manner, as  has been suggested to occur in 
other tissues (Xu et al., 1996; Todisco et al., 1997; and 
for review, Crawley and Corvin, 1994). 
It is current knowledge that adrenal growth in 
immature animals and adrenal regeneration after 
enucleation are processes strictly dependent on the 
pituitary ACTH release (for review, see Nussdorfer, 
1986), and compelling evidence indicates that CCK is 
able to activate the entire hypothalamo-pituitary-adrenal 
(HPA) axis. CCK was found to be CO-localized with 
corticotropin-releasing hormone (CRH) and vasopressin 
in the paraventricular nucleus (Kiss et al., 1984; Mezey 
et al., 1986; Ceccatelli et al., 1989) and in the external 
layer of the median eminence adjacent to portal 
capillaries (Anhut et al., 1983). CCK protein and mRNA 
were detected in the anterior pituitary gland (Houben 
and Deneff, 1994), and CCWgastrin binding sites were 
demonstrated in the pars distalis of the goldfish pituitary 
gland (Himmick et al., 1996). The systemic adminis- 
tration of CCK was  reported to raise ACTH and 
glucocorticoid blood levels in rats, and to activate 
paraventricular nucleus, acting through the CCK-A 
receptor subtype (Itoh et al., 1979a,b, 1982; Kamilaris et 
al., 1992; Katsuura et al., 1992; Calogero et al., 1993; 
Monnikes et al., 1997). Hence, it seems reasonable to 
admit that the adrenocortical proliferogenic action of 
CCK may be, at least in part, indirect and mediated by 
the stimulation of pituitary ACTH release. Obviously, 
the synthesis of CCK in adrenal medulla and the 
presence of CCK-A receptors in medullary cells (see 
Introduction) makes the possibility that CCK may also 
activate adrenocortical-cell proliferation in a paracrine 
manner likely, at least when the integrity of the gland is 
preserved. In this connection, it is to be recalled that rat 
adrenal medulla contains an active CRHtACTH system 
(Andreis et al., 1991, 1992; Mazzocchi et al., 1993), 
which is involved in the paracrine control not only of the 
cortical secretion (for review, see Nussdorfer, 1996; 
Mazzocchi et al., 1998), but also of adrenal growth 
(Mazzocchi et al., 1994). However, it is evident that this 
paracrine mechanism cannot underly the stimulating 
effect of CCK on adrenal regeneration, inasmuch as 
enucleation eliminates adrenal medulla. 
In vivo studies suggest that CCK exerts an immuno- 
modulatory effect, since it is able to restore thymus- 
dependent immune responses in thymectomized mice 
and to stimulate IgM-plaque forming cells (Belokrylov 
et al., 1990; Molchanova et al., 1992). Our present 
findings are in keeping with this contention. In fact, 
CCK-A receptor activation by CCK markedly enhances 
thymocyte proliferation, 25% of which takes place in the 
thymus cortex, and especially in the subcapsular zone, 
which is considered the region where thymopoiesis 
initiates (Scollay and Shortman, 1985; Boyd and Hugo, 
1991; Scollay and Godfrey, 1995). Although CCK and 
i ts  receptors are both present in the thymus (see 
Introduction), in vitro studies did not reveal any effect of 
this peptide or pentagastrin (a CCK-A receptor agonist) 
on the mitotic activity of cultured human thymocytes, 
guinea-pig T lymphocytes and rat B lymphocytes (Soder 
and Hellstrom, 1987), thereby making unlikely the 
possibility of a direct action of CCK on thymus. At 
present, only tentative hypotheses can be advanced to 
explain the indirect mechanism whereby CCK stimulates 
thymus growth. There is proof that glucocorticoids, in 
addi t ion to  enhancing lymphocytolysis ,  are  also 
necessary for the intrathymic thymocyte survival and 
differentiation in young animals (Compton et al., 1987; 
Vacchio et al., 1994), and that the HPA axis is still 
hypofunctioning in immature rats (for review, see 
Nussdorfer, 1986). In light of these considerations, it 
seems not unreasonable to conceive that the CCK 
proliferogenic action on thymocytes may be consequent 
to its stimulatory effect on the HPA axis. 
To summarize, we have demonstrated that CCK, via 
the CCK-A receptor subtype, stimulates the proliferation 
of (i) rat adrenocortical cells in experimental models in 
which adrenal gland undergoes a rapid growth, and (ii) 
thymocytes in immature rats. The hypothesis has been 
advanced that both effects are dependent on the CCK- 
induced central activation of the HPA axis. Before 
concluding, a few words of caution stressing that the 
physiological relevance of these proliferogenic actions 
of CCK remain to be demonstrated. In fact, the finding 
that the administration of the CCK-A receptor antagonist 
alone does not affect mitotic rate in both adrenal and 
thymus would suggest that endogenous CCK does not 
play a major role in either the maintenance of normal 
adrenal and thymus growth in immature rats or the 
stimulation of adrenal regeneration in adult animals. 
Further studies are needed, employing higher doses of 
CCK receptor antagonists and possibly more prolonged 
treatments also using continuous infusion with osmotic 
pumps. 
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